Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; 3 of the 7 sources its claims cite were checked for support.

Surveillance to track progress toward polio eradication—worldwide, 2020–2021.

Open access
Wilkinson, Amanda L., Diop, Ousmane M., Jorba, Jaume, Gardner, Tracie, Snider, Cynthia J., Ahmed, Jamal · 2022 · MMWR Morbidity and Mortality Weekly Report

Abstract

Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%.By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan).However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020-2021 (1,2).cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis.The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance).The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January-September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3).This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4).In 2021, a total of 32 (74%) priority countries † met * Countries selected for this 2020-2021 report were identified as priority countries in the WHO Global Polio Surveillance Action Plan (GPSAP), 2022-2024 because of persistent surveillance gaps and susceptibility to poliovirus transmission or had ≥1 WPV1 or cVDPV isolates detected from AFP or environmental surveillance in 2021

Overview

CoChat Summary

TL;DR

This report summarizes 2020–2021 polio surveillance performance in 43 priority countries and finds that national AFP surveillance improved in 2021, especially in the African Region, but substantial national and subnational gaps remained. The paper also shows that environmental surveillance and GPLN testing continued to detect cVDPV and WPV circulation, including a WPV1 case in Malawi in 2021.

Key findings

  • In 2021, 32/43 (74%) priority countries met both national AFP surveillance indicator targets, up from 23/43 (53%) in 2020.
  • In the African Region, 50% of 28 priority countries met both national targets in 2020 and 79% did in 2021; at the first subnational administrative level, 52% met both targets in 2020 and 75% in 2021.
  • In 2020–2021, environmental surveillance detected cVDPV2 before a confirmed AFP case in Afghanistan, Liberia, and Senegal, and detected it only through sewage in Djibouti, Egypt, Gambia, Iran, Mauritania, and Uganda.
  • GPLN tested 147,582 stool specimens in 2020 and 170,881 in 2021; cVDPVs were isolated from 1,067 AFP cases in 2020 and 659 in 2021.

Methods

  • The report reviewed surveillance indicators for 43 priority countries at risk for poliovirus transmission, using two AFP performance measures: nonpolio AFP rate ≥2 per 100,000 children aged <15 years and stool adequacy ≥80%.
  • It summarized AFP surveillance, environmental surveillance, and GPLN laboratory data for 2020 and 2021, with regional and subnational comparisons.
  • Main analyses were descriptive, reporting counts, percentages, and changes over time by WHO region and country.

Limitations

  • The paper states that security issues and hard-to-access populations could affect AFP surveillance and limit interpretation of surveillance indicators.
  • It states that high NPAFP rates do not necessarily mean highly sensitive surveillance because some reported cases may not meet the case definition, some AFP cases may go undetected, and background NPAFP rates may vary.
  • It states that stool adequacy depends on accurate paralysis onset dates from field investigations. Evidence in the text also suggests a limitation: the report is descriptive surveillance monitoring, so it does not estimate causal effects of COVID-19 or other factors beyond observed changes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.15585/mmwr.mm7115a2

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE Combined performance indicators for the quality of acute flaccid paralysis surveillance* in subnational areas of 43 priority countries — World Health Organization African, Eastern Mediterranean, South-East Asia, and Western Pacific regions, 2021 Abbreviations: AFP = acute flaccid paralysis; NPAFP = nonpolio acute flaccid paralysis; WHO = World Health Organization. * Targets: ≥2 NPAFP cases per 100,000 persons aged <15 years per year and ≥80% of persons with AFP having two stool specimens collected ≥24 hours apart and within 14 days of paralysis onset, and arrival at a WHO-accredited laboratory by reverse cold chain (storing and transporting samples at recommended temperatures from the point of collection to the laboratory) and in good condition (i.e., without leakage or desiccation).
FIGURE Combined performance indicators for the quality of acute flaccid paralysis surveillance* in subnational areas of 43 priority countries — World Health Organization African, Eastern Mediterranean, South-East Asia, and Western Pacific regions, 2021 Abbreviations: AFP = acute flaccid paralysis; NPAFP = nonpolio acute flaccid paralysis; WHO = World Health Organization. * Targets: ≥2 NPAFP cases per 100,000 persons aged <15 years per year and ≥80% of persons with AFP having two stool specimens collected ≥24 hours apart and within 14 days of paralysis onset, and arrival at a WHO-accredited laboratory by reverse cold chain (storing and transporting samples at recommended temperatures from the point of collection to the laboratory) and in good condition (i.e., without leakage or desiccation).CC0 · PubMed Central

Verification

Claims the paper makes

3 Valid · 1 Not valid · 5 Not checked · 47 Own results and interpretations

40 more claims

Create a free account to see all 56 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Cited by

See all 30

Metadata

Authors
Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., & Ahmed, J.
Affiliations
National Center for Immunization and Respiratory Diseases (US)
Corresponding author
Wilkinson, Amanda L.
Venue
MMWR Morbidity and Mortality Weekly Report
Published
2022-04-15
Volume
71
Issue
15
Pages
538-544
ISSN
  • 0149-2195 (ISSN-L)
  • 1545-861X
OpenAlex
W4225529761
Cited by
30
References
14
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 14 · 2022: 6
FWCI
4.87
Type
journal article
Language
en
Open access
Locations
  • MMWR Morbidity and Mortality Weekly Report (publishedVersion)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
  • Centers for Disease Control and Prevention
  • National Center for Immunization and Respiratory Diseases
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Keywords
polio eradication, acute flaccid paralysis surveillance, wild poliovirus type 1, circulating vaccine-derived poliovirus, environmental surveillance, poliovirus transmission, COVID-19 pandemic impact on vaccination
MeSH terms
COVID-19, Humans, Paralysis, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Global Health, Immunization Programs, Poliovirus, Pandemics, Disease Eradication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Surveillance to track progress toward polio eradication—worldwide, 2020–2021. https://app.cochat.ai/papers/10.15585/mmwr.mm7115a2
The paper
Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., & Ahmed, J. (2022). Surveillance to track progress toward polio eradication—worldwide, 2020–2021. MMWR Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7115a2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.